Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer
Chelsea Bolyard(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Balveen Kaur(Augusta University), Timothy P. Cripe(Nationwide Children's Hospital), Karuppaiyah Selvendiran(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Pin-Yi Wang(Nationwide Children's Hospital), Jianying Zhang(Shanxi Agricultural University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Uksha Saini(Ohio State University Hospital), Kellie S. Rath(Gynecologic Oncology Group)
Cited by 32
Related Papers
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360
Characterization of differential properties of rabbit tendon stem cells and tenocytes
|BMC Musculoskeletal Disorders|2010|345
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332